Search research articles
Contact Us
Filters
Showing results (31-40 of 43) with videos related to
Page
of 5
Sort By:
Cephalalgia : an International Journal of Headache
|
May 1, 1997
Naratriptan: biological profile in animal models relevant to migraine
H E Connor, W Feniuk, D T Beattie, et al.
Infection and Immunity
|
July 1, 1995
Heterologous antigen expression in Vibrio cholerae vector strains
J R Butterton, D T Beattie, C L Gardel, et al.
Vascular Pharmacology
|
December 4, 2012
An in vitro investigation of the cardiovascular effects of the 5-HT(4) receptor selective agonists, velusetrag and TD-8954
D T Beattie, D L Higgins, M P Ero, et al.
Regulatory Peptides
|
August 27, 1996
GR205171: a novel antagonist with high affinity for the tachykinin NK1 receptor, and potent broad-spectrum anti-emetic activity
C J Gardner, D R Armour, D T Beattie, et al.
British Journal of Pharmacology
|
February 13, 2007
A comparison of the pharmacological properties of guinea-pig and human recombinant 5-HT4 receptors
R G Vickery, N Mai, E Kaufman, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
April 15, 2008
The in vivo gastrointestinal activity of TD-5108, a selective 5-HT(4) receptor agonist with high intrinsic activity
D T Beattie, S R Armstrong, J P Shaw, et al.
British Journal of Pharmacology
|
December 1, 1995
The pharmacology of GR203040, a novel, potent and selective non-peptide tachykinin NK1 receptor antagonist
D T Beattie, I J Beresford, H E Connor, et al.
Journal of Medicinal Chemistry
|
January 1, 1991
Novel class of amino acid antagonists at non-N-methyl-D-aspartic acid excitatory amino acid receptors. Synthesis, in vitro and in vivo pharmacology, and neuroprotection
P Krogsgaard-Larsen, J W Ferkany, E O Nielsen, et al.
The Journal of Infectious Diseases
|
December 1, 1994
Development of a live, oral, attenuated vaccine against El Tor cholera
D N Taylor, K P Killeen, D C Hack, et al.
The Journal of Infectious Diseases
|
October 1, 1995
Peru-15, an improved live attenuated oral vaccine candidate for Vibrio cholerae O1
J R Kenner, T S Coster, D N Taylor, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 43) with videos related to
Sort By:
Page
of 5
Cephalalgia : an International Journal of Headache
|
May 1, 1997
Naratriptan: biological profile in animal models relevant to migraine
H E Connor, W Feniuk, D T Beattie, et al.
Infection and Immunity
|
July 1, 1995
Heterologous antigen expression in Vibrio cholerae vector strains
J R Butterton, D T Beattie, C L Gardel, et al.
Vascular Pharmacology
|
December 4, 2012
An in vitro investigation of the cardiovascular effects of the 5-HT(4) receptor selective agonists, velusetrag and TD-8954
D T Beattie, D L Higgins, M P Ero, et al.
Regulatory Peptides
|
August 27, 1996
GR205171: a novel antagonist with high affinity for the tachykinin NK1 receptor, and potent broad-spectrum anti-emetic activity
C J Gardner, D R Armour, D T Beattie, et al.
British Journal of Pharmacology
|
February 13, 2007
A comparison of the pharmacological properties of guinea-pig and human recombinant 5-HT4 receptors
R G Vickery, N Mai, E Kaufman, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
April 15, 2008
The in vivo gastrointestinal activity of TD-5108, a selective 5-HT(4) receptor agonist with high intrinsic activity
D T Beattie, S R Armstrong, J P Shaw, et al.
British Journal of Pharmacology
|
December 1, 1995
The pharmacology of GR203040, a novel, potent and selective non-peptide tachykinin NK1 receptor antagonist
D T Beattie, I J Beresford, H E Connor, et al.
Journal of Medicinal Chemistry
|
January 1, 1991
Novel class of amino acid antagonists at non-N-methyl-D-aspartic acid excitatory amino acid receptors. Synthesis, in vitro and in vivo pharmacology, and neuroprotection
P Krogsgaard-Larsen, J W Ferkany, E O Nielsen, et al.
The Journal of Infectious Diseases
|
December 1, 1994
Development of a live, oral, attenuated vaccine against El Tor cholera
D N Taylor, K P Killeen, D C Hack, et al.
The Journal of Infectious Diseases
|
October 1, 1995
Peru-15, an improved live attenuated oral vaccine candidate for Vibrio cholerae O1
J R Kenner, T S Coster, D N Taylor, et al.
Page
of 5